In 64 adults with cocaine use disorder, clavulanic acid (500–750mg/day) for 12 weeks gave no significant overall improvement vs placebo. In subgroup analysis, women had a median 4.0 vs 0.6 more cocaine-free days/week; men showed no benefit.
RCTn = 64
Maser et al. Efficacy signals in a 12-week trial of clavulanic acid to decrease cocaine use